Psychiatric Times

10/30/2025

Nutriband announced a successful feedback meeting with the FDA regarding their abuse deterrent fentanyl patch. The patch's proposed indication is pain management for patients with op**te tolerance who require daily and constant long term op**te treatment.

Nutriband engages with the FDA on its innovative abuse-deterrent fentanyl patch, paving the way for safer pain management solutions.

10/29/2025

Today is .

Understanding what lies ahead in the road to stroke recovery can help patients and their families prepare for the challenges they will face. Learn more here: https://www.psychiatrictimes.com/view/beyond-survival-understanding-the-long-road-to-stroke-recovery

10/28/2025

According to new positive phase 3 results, CTx-1301 for the treatment of pediatric ADHD delivered rapid onset of effect and sustained efficacy through the evening hours. https://www.psychiatrictimes.com/view/positive-phase-3-results-ctx-1301-for-the-treatment-of-pediatric-adhd

10/27/2025

Catatonia can present with overlapping symptoms of other neuropsychiatric conditions, complicating diagnosis and treatment, especially in critical care settings.

In this CME article, explore the complexities of diagnosing and managing catatonia in patients with overlapping neuropsychiatric conditions.

10/24/2025

🗞️Need weekend reading? The entire October issue of Psychiatric Times is now live on our website. Read it here: https://www.psychiatrictimes.com/journals/psychiatric-times/vol-42-issue-10

10/24/2025

Creative patients often experience loneliness, which can be both a challenge and a source of inspiration. How can you as a clinician help them reframe the meaning of their experience in terms of solitude?

Creative individuals navigate the fine line between solitude and loneliness, discovering how isolation can fuel artistic expression or lead to despair.

10/23/2025

A recent study reveals that the choice of initial antipsychotic significantly impacts long-term weight gain over 5 years.

A recent study reveals that the choice of initial antipsychotic significantly impacts long-term weight gain, highlighting the complexity of treatment outcomes.

10/22/2025

Insomnia in older adults is linked to accelerated aging and various medical conditions, with nearly 50% reporting sleep issues and 20% meeting insomnia disorder criteria.

Explore the complexities of insomnia in older adults, its impact on health, and effective management strategies for improved sleep quality.

10/20/2025

Learn more about the historical and clinical features commonly used clinically to distinguish dementia from intoxication/withdrawal syndromes and to differentiate among the most common dementia syndromes. https://www.psychiatrictimes.com/view/precision-diagnosis-the-new-paradigm-for-neurocognitive-disorders

10/17/2025

Pediatricians are on the front lines of ADHD care.
Hear experts discuss their essential role—and the challenges they face—in diagnosis and long-term management. Tune in to the full discussion here: https://hubs.li/Q03B6f5Z0

10/17/2025

New analysis reveals that the 40 mg dose of once-daily Ingrezza capsules experienced clinically meaningful improvements in tardive dyskinesia symptoms.

New analysis reveals Ingrezza's 40 mg dose significantly improves tardive dyskinesia symptoms, showcasing long-term efficacy and safety in patients.

10/16/2025

According to Jennifer L. Payne, MD, women are being subtly and not so subtly encouraged to ignore their own needs in favor of having a pregnancy that is not exposed to any medications, leading to worse physical and mental health outcomes.

A reproductive psychiatrist discusses the implications of recent FDA announcements on medication use during pregnancy, emphasizing the importance of mental health for mothers and babies.